Optie A:
Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
Optie B:
Deel de link per e-mail
Link delen

vorige artikel Self-Reported Depressive Symptoms Have Minimal ...

volgende artikel Parent Perspectives of an Evidence-Based Interv...

Tip

Swipe om te navigeren naar een ander artikel

01-04-2013 | Review Paper | Uitgave 3/2013

Translation of Anxiety Treatment to Youth with Autism Spectrum Disorders

Tijdschrift:: Journal of Child and Family Studies > Uitgave 3/2013

Auteurs:: Robert R. Selles, Eric A. Storch

» Toegang tot de volledige tekst krijgen

Abstract

Clinically significant anxiety affects many youth with autism spectrum disorders (ASD) and is associated with a number of functional consequences. Building from treatment approaches of anxiety in typically developing populations, pharmacological and psychotherapeutic approaches to treating anxiety in ASD are being increasingly examined. Despite being commonly prescribed, there is limited empirical support beyond open trials and case series at present for the use of antidepressants or anxiolytics in the treatment of anxiety for youth with ASD. A modest body of evidence exists supporting the application of a modified form of cognitive-behavioral therapy, with associated reductions in anxiety and some core autism improvements. Further research, refinement and replication is needed to establish the efficacy of treatment approaches for anxiety in youth with ASD, what treatment component(s) are most appropriate for which patients, what factors may play an integral role in treatment outcomes, and whether treatments result in durable and generalizable gains.

Log in om toegang te krijgen

Hier inloggen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Psychologie Totaal

Met BSL houdt u eenvoudig en efficiënt uw vak bij. Met een online abonnement heeft u toegang tot een groot aantal boeken, tijdschriften en online nascholing. Denk hierbij aan e-learnings en web-tv's. Zo kunt u op uw gemak en wanneer het u het beste uitkomt verdiepen in uw vakgebied.

Meer informatie

Abramowitz, J. S., Whiteside, S. P., & Deacon, B. J. (2005). The effectiveness of treatment for pediatric obsessive compulsive disorder: A meta-analysis. Behavior Therapy, 36, 55–63. CrossRef

Abramowitz, J. S., Khandker, M., Nelson, C. A., Deacon, B. J., & Rygwall, R. (2006). The role of cognitive factors in the pathogenesis of obsessive-compulsive symptoms: A prospective study. Behaviour Research and Therapy,44(9), 1361–1374. PubMedCrossRef

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders— fourth edition— text revision. Washington, DC.

Arnold, L. E., Farmer, C., Kraemer, H. C., Davies, M., Witwer, A., Chuang, S., et al. (2010). Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. Journal of Child and Adolescent Psychopharmacology,20(2), 83–93. PubMedCrossRef

Attwood, T. (2003). Framework for behavioral interventions. Child and Adolescent Psychiatric Clinics of North America,12, 65–86. PubMedCrossRef

Autism Speaks. (2009, February 18). Autism speaks announces results reported for the study of floxetine in autism (SOFIA), first industry-sponsored trial for the autism clinical trials network (ACTN). In Autism speaks. Retrieved January 20, 2012.

Baron-Cohen, S. (1989). Do autistic children have obsessions and compulsions? British Journal of Clinical Psychology,28(3), 193–200. PubMedCrossRef

Baron-Cohen, S., Mortimore, C., Moriarty, J., Izaguirre, J., & Robertson, M. (1999). The prevalence of gilles de la tourette’s syndrome in children and adolescents with autism. Journal of Child Psychology and Psychiatry,40(2), 213–218. PubMedCrossRef

Bellini, S. (2004). Social skill deficits and anxiety in high-functioning adolescents with autism spectrum disorders. Focus on Autism and Other Developmental Disabilities,19, 78–86. CrossRef

Ben-Sasson, A., Cermak, S. A., Orsmond, G. I., Tager-Flusberg, H., Kadlec, M. B., & Carter, A. S. (2008). Sensory clusters of toddlers with autism spectrum disorders: Differences in affective symptoms. Journal of Child Psychology and Psychiatry,49(8), 817–825. PubMedCrossRef

Boyd, K., Woodbury-Smith, M., & Szatmari, P. (2011). Managing anxiety and depressive symptoms in adults with autism-spectrum disorders. Journal of Psychiatry and Neuroscience,36(4), E35–E36. PubMedCrossRef

Buitelaar, J. K., van der Gaag, R. J., & van der Hoeven, J. (1998). Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: Results of an open-label study. Journal of Clinical Psychiatry,59(2), 56–59. PubMedCrossRef

Cardaciotto, L., & Herbert, J. D. (2004). Cognitive behavior therapy for social anxiety disorder in the context of Asperger’s Syndrome: A single-subject report. Cognitive and Behavioral Practice,11(1), 75–81. CrossRef

CDC. (2012). Prevalence of autism spectrum disorders—autism and developmental disabilities monitoring network, 14 Sites, United States, 2008. MMWR Surveillance Summaries,61(3), 1–24.

Chalfant, A. M., Rapee, R., & Carroll, L. (2007). Treating anxiety disorders in children with high functioning autism spectrum disorders: A controlled trial. Journal of Autism and Developmental Disorders,37(10), 1842–1857. PubMedCrossRef

Constantino, J. N., & Gruber, C. P. (2005). The social responsiveness scale (SRS) manual. Los Angeles: Western Psychological Services.

Cotugno, A. J. (2009). Social competence and social skills training and intervention for children with autism spectrum disorders. Journal of Autism and Developmental Disorders,39(9), 1268–1277. PubMedCrossRef

Couturier, J. L., & Nicolson, R. (2002). A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology,12(3), 243–248. PubMedCrossRef

Davis, T. E., Moree, B. N., Dempsey, T., Hess, J. A., Jenkins, W. S., Fodstad, J. C., et al. (2011). The effect of communication deficits on anxiety symptoms in infants and toddlers with autism spectrum disorders. Behavior Therapy,43(1), 142–152. PubMedCrossRef

de Bruin, E. I., Ferdinand, R. F., Meester, S., de Nijs, P. F., & Verheij, F. (2007). High rates of psychiatric co-morbidity in PDD-NOS. Journal of Autism and Developmental Disorders,37(5), 877–886. PubMedCrossRef

Deacon, B. J., & Abramowitz, J. S. (2004). Cognitive and behavioral treatments for anxiety disorders: A review of meta-analytic findings. Journal of Clinical Psychology,60(4), 429–441. PubMedCrossRef

DeLong, G. R., Ritch, C. R., & Burch, S. (2002). Fluoxetine response in children with autistic spectrum disorders: Correlation with familial major affective disorder and intellectual achievement. Developmental Medicine and Child Neurology,44(10), 652–659. PubMedCrossRef

DeLong, G. R., Teague, L. A., & McSwain Kamran, M. (1998). Effects of fluoxetine treatment in young children with idiopathic autism. Developmental Medicine and Child Neurology,40(8), 551–562. PubMedCrossRef

Drahota, A., Wood, J. J., Sze, K. M., & Van Dyke, M. (2011). Effects of cognitive behavioral therapy on daily living skills in children with high-functioning autism and concurrent anxiety disorders. Journal of Autism and Developmental Disorders,41(3), 257–265. PubMedCrossRef

Durham, R. C., Chambers, J. A., MacDonald, R. R., Power, K. G., & Major, K. (2003). Does cognitive-behavioural therapy influence the long-term outcome of generalized anxiety disorder? An 8–14 year follow-up of two clinical trials. Psychological Medicine,33(3), 499–509. PubMedCrossRef

Ehrenreich, J. T., Simpson, G., & Wood, J. J. (2009). Anxiety-focused interventions for youth with autism: Manual for adolescents transitioning to adulthood. University of Miami. Unpublished treatment manual.

Fombonne, E. (2009). Epidemiology of pervasive developmental disorders. Pediatric Research,65(6), 591–598. PubMedCrossRef

Gadow, K. D., Devincent, C. J., Pomeroy, J., & Azizian, A. (2005). Comparison of DSM-IV symptoms in elementary school-age children with PDD versus clinic and community samples. Autism,9(4), 392–415. PubMedCrossRef

Gadow, K. D., Devincent, C., & Schneider, J. (2008). Predictors of psychiatric symptoms in children with an autism spectrum disorder. Journal of Autism and Developmental Disorders,38(9), 1710–1720. PubMedCrossRef

Garcia-Lopez, L. J., Olivares, J., Beidel, D., Albano, A. M., Turner, S., & Rosa, A. I. (2006). Efficacy of three treatment protocols for adolescents with social anxiety disorder: A 5-year follow-up assessment. Journal of Anxiety Disorders,20(2), 175–191. PubMedCrossRef

Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Martin, A., Spencer, T., et al. (2003). Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. American Journal of Psychiatry,160(11), 1919–1928. PubMedCrossRef

Ghaziuddin, M., Ghaziuddin, N., & Greden, J. (2002). Depression in persons with autism: Implications for research and clinical care. Journal of Autism and Developmental Disorders,32(4), 299–306. PubMedCrossRef

Gillott, A., Furniss, F., & Walter, A. (2001). Anxiety in high-functioning children with autism. Autism,5(3), 277–286. PubMedCrossRef

Green, S. A., Ben-Sasson, A., Soto, T. W., & Carter, A. S. (2011). Anxiety and sensory over-responsivity in toddlers with autism spectrum disorders: Bidirectional effects across time. Journal of Autism and Developmental Disorders.

Henry, C. A., Steingard, R., Venter, J., Guptill, J., Halpern, E. F., & Bauman, M. (2006). Treatment outcome and outcome associations in children with pervasive developmental disorders treated with selective serotonin reuptake inhibitors: A chart review. Journal of Child and Adolescent Psychopharmacology,16(1/2), 187–195. PubMedCrossRef

Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman, S., et al. (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology,30(3), 582–589. PubMedCrossRef

Hwang, B., & Hughes, C. (2000). The effects of social interactive training on early social communicative skills of children with autism. Journal of Autism and Developmental Disorders,30, 331–343. PubMedCrossRef

Kanner, L. (1943). Autistic disturbances of affective contact. The Nervous Child,2, 217–250.

Kelly, A. B., Garnett, M. S., Attwood, T., & Peterson, C. (2008). Autism spectrum symptomatology in children: The impact of family and peer relationships. Journal of Abnormal Child Psychology,36(7), 1069–1081. PubMedCrossRef

Kendall, P. C., & Choudhury, M. S. (2003). Children and adolescents in cognitive–behavioral therapy: Some past efforts and current advances, and the challenges in our future. Cognitive Therapy and Research,27(1), 89–104. CrossRef

Kendall, P. C., Hudson, J. L., Gosch, E., Flannery-Schroeder, E., & Suveg, C. (2008). Cognitive-behavioral therapy for anxiety disordered youth: a randomized clinical trial evaluating child and family modalities. Journal of Consulting and Clinical Psychology,76(2), 282–297. PubMedCrossRef

Kendall, P. C., Safford, S., Flannery-Schroeder, E., & Webb, A. (2004). Child anxiety treatment: Outcomes in adolescence and impact on substance use and depression at 7.4-year follow-up. Journal of Consulting and Clinical Psychology,72(2), 276–287. PubMedCrossRef

Kim, J. A., Szatmari, P., Bryson, S. E., Streiner, D. L., & Wilson, F. J. (2000). The prevalence of anxiety and mood problems among children with autism and Asperger syndrome. Autism,4(2), 117. CrossRef

King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., et al. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Archives of General Psychiatry,66(6), 583–590. PubMedCrossRef

Klin, A., Danovitch, J. H., Merz, A. B., & Volkmar, F. R. (2007). Circumscribed interests in higher functioning individuals with autism spectrum disorders: An exploratory study. Research and Practice for Persons with Severe Disabilities,32(2), 89–100. CrossRef

Lang, R., Regester, A., Lauderdale, S., Ashbaugh, K., & Haring, A. (2010). Treatment of anxiety in autism spectrum disorders using cognitive behaviour therapy: A systematic review. Developmental Neurorehabilitation,13(1), 53–63. PubMedCrossRef

Leskovec, T. J., Rowles, B. M., & Findling, R. L. (2008). Pharmacological treatment options for autism spectrum disorders in children and adolescents. Harvard Review of Psychiatry,16(2), 97–112. PubMedCrossRef

Levant, R. F. (2005). Report of the 2005 presidential task force on evidence-based practice. In American psychological association. Retrieved March 31, 2012, from http://www.apa.org/practice/resources/evidence/evidence-based-report.pdf.

Leyfer, O. T., Folstein, S. E., Bacalman, S., Davis, N. O., Dinh, E., Morgan, J., et al. (2006). Comorbid psychiatric disorders in children with autism: Interview development and rates of disorders. Journal of Autism and Developmental Disorders,36(7), 849–861. PubMedCrossRef

Lord, C., Wagner, A., Rogers, S., Szatmari, P., Aman, M., Charman, T., et al. (2005). Challenges in evaluating psychosocial interventions for autistic spectrum disorders. Journal of Autism and Developmental Disorders,35(6), 695–708. Discussion 709–611. PubMedCrossRef

Manassis, K., Avery, D., Butalia, S., & Mendlowitz, S. (2004). Cognitive-behavioral therapy with childhood anxiety disorders: Functioning in adolescence. Depression and Anxiety,19(4), 209–216. PubMedCrossRef

Mancuso, E., Faro, A., Joshi, G., & Geller, D. A. (2010). Treatment of pediatric obsessive-compulsive disorder: A review. Journal of Child and Adolescent Psychopharmacology,20(4), 299–308. PubMedCrossRef

Martin, A., Koenig, K., Anderson, G. M., & Scahill, L. (2003). Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study. Journal of Autism and Developmental Disorders,33(1), 77–85. PubMedCrossRef

Matson, J. L., & Shoemaker, M. (2009). Intellectual disability and its relationship to autism spectrum disorders. Research in Developmental Disabilities,30(6), 1107–1114. PubMedCrossRef

McCormick, L. H. (1997). Treatment with buspirone in a patient with autism. Archives of Family Medicine,6(4), 368–370. PubMedCrossRef

McDougle, C. J., Brodkin, E. S., Naylor, S. T., Carlson, D. C., Cohen, D. J., & Price, L. H. (1998). Sertraline in adults with pervasive developmental disorders: A prospective open-label investigation. Journal of Clinical Psychopharmacology,18(1), 62–66. PubMedCrossRef

McDougle, C. J., Kresch, L. E., & Posey, D. J. (2000). Repetitive thoughts and behavior in pervasive developmental disorders: Treatment with serotonin reuptake inhibitors. Journal of Autism and Developmental Disorders,30(5), 427–435. PubMedCrossRef

McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry,53(11), 1001–1008. PubMedCrossRef

Mercier, C., Mottron, L., & Belleville, S. (2000). A psychosocial study on restricted interests in high functioning persons with pervasive developmental disorders. Autism,4(4), 406–425. CrossRef

Mills, R., & Wing, L. (2005). Researching interventions in ASD and priorities for research: Surveying the membership of the NAS. London: National Autistic Society.

Muris, P., Steerneman, P., Merckelbach, H., Holdrinet, I., & Meesters, C. (1998). Comorbid anxiety symptoms in children with pervasive developmental disorders. Journal of Anxiety Disorders,12(4), 387–393. PubMedCrossRef

Murphy, T. K., Segarra, A., Storch, E. A., & Goodman, W. K. (2008). SSRI adverse events: How to monitor and manage. International Review of Psychiatry, 20(2), 203–208. PubMedCrossRef

Namerow, L. B., Thomas, P., Bostic, J. Q., Prince, J., & Monuteaux, M. C. (2003). Use of citalopram in pervasive developmental disorders. Journal of Developmental and Behavioral Pediatrics,24(2), 104–108. PubMedCrossRef

Ooi, Y. P., Lam, C. M., Sung, M., Tan, W. T., Goh, T. J., Fung, D. S., et al. (2008). Effects of cognitive-behavioural therapy on anxiety for children with high-functioning autistic spectrum disorders. Singapore Medical Journal,49(3), 215–220. PubMed

Oswald, D. P., & Sonenklar, N. A. (2007). Medication use among children with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology,17(3), 348–355. PubMedCrossRef

Posey, D. I., Litwiller, M., Koburn, A., & McDougle, C. J. (1999). Paroxetine in autism. Journal of the American Academy of Child and Adolescent Psychiatry,38(2), 111–112. PubMedCrossRef

Rao, P. A., Beidel, B. C., & Murray, M. J. (2008). Social skills interventions for children with Asperger’s syndrome or high-functioning autism: A review and recommendations. Journal of Autism and Developmental Disorders,38, 353–361. PubMedCrossRef

Realmuto, G. M., August, G. J., & Garfinkel, B. D. (1989). Clinical effect of buspirone in autistic children. Journal of Clinical Psychopharmacology,9(2), 122–125. PubMedCrossRef

Reaven, J., Blakeley-Smith, A., Culhane-Shelburne, K., & Hepburn, S. (2012). Group cognitive behavior therapy for children with high-functioning autism spectrum disorders and anxiety: A randomized trial. Journal of Child Psychology and Psychiatry, 53(4), 410–419. PubMedCrossRef

Rufer, M., Hand, I., Alsleben, H., Braatz, A., Ortmann, J., Katenkamp, B., et al. (2005). Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: A 7-year follow-up of a randomized double-blind trial. European Archives of Psychiatry and Clinincal Neuroscience,255(2), 121–128. CrossRef

RUPP (Research Unit on Pediatric Psychopharmacology) Anxiety Study Group. (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine,344(17), 1279–1285. CrossRef

Russell, A. J., Mataix-Cols, D., Anson, M., & Murphy, D. G. (2005). Obsessions and compulsions in Asperger syndrome and high-functioning autism. British Journal of Psychiatry,186, 525–528. PubMedCrossRef

Russell, E., & Sofronoff, K. (2005). Anxiety and social worries in children with Asperger syndrome. Australian and New Zealand Journal of Psychiatry,39(7), 633–638. PubMedCrossRef

Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child and Adolescent Psychiatry,47(8), 921–929. PubMedCrossRef

Snead, R. W., Boon, F., & Presberg, J. (1994). Paroxetine for self-injurious behavior. Journal of the American Academy of Child and Adolescent Psychiatry,33(6), 909–910. PubMedCrossRef

Sofronoff, K., Attwood, T., & Hinton, S. (2005). A randomised controlled trial of a CBT intervention for anxiety in children with Asperger syndrome. Journal of Child Psychology and Psychiatry,46(11), 1152–1160. PubMedCrossRef

Spiker, M. A., Lin, C. E., Van Dyke, M., & Wood, J. J. (2011). Restricted interests and anxiety in children with autism. Autism,. doi: 10.1177/1362361311401763. PubMed

Steingard, R. J., Zimnitzky, B., DeMaso, D. R., Bauman, M. L., & Bucci, J. P. (1997). Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. Journal of Child and Adolescent Psychopharmacology,7(1), 9–15. PubMedCrossRef

Stewart, R. E., & Chambless, D. L. (2009). Cognitive-behavioral therapy for adult anxiety disorders in clinical practice: A meta-analysis of effectiveness studies. Journal of Consulting and Clinical Psychology,77(4), 595–606. PubMedCrossRef

Storch, E. A., Ehrenreich-May, J., Wood, J. J., Jones, A. M., De Nadai, A. S., Lewin., & A. B., Murphy, T. K. (in press). Multiple informant agreement on the anxiety disorders interview schedule in youth with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology.

Storch, E. A., Geffken, G. R., Merlo, L. J., Jacob, M. L., Murphy, T. K., Goodman, W. K., et al. (2007). Family accommodation in pediatric obsessive-compulsive disorder. Journal of Clinical Child and Adolesc Psychology,36(2), 207–216. CrossRef

Storch, E. A., Mariaskin, A., & Murphy, T. K. (2009). Psychotherapy for obsessive-compulsive disorder. Current Psychiatry Reports,11(4), 296–301. PubMedCrossRef

Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine,359(26), 2753–2766. PubMedCrossRef

Warren, Z., Veenstra-VanderWeele, J., Stone, W., Bruzek, J. L., Nahmias, A. S., Foss-Feig, J. H., & McPheeters, M. L. (2011). Therapies for children with autism spectrum disorders. Comparative effectiveness review, 12 edn, vol. 26. Rockville, MD: Agency for Healthcare Research and Quality.

Weisbrot, D. M., Gadow, K. D., DeVincent, C. J., & Pomeroy, J. (2005). The presentation of anxiety in children with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology,15(3), 477–496. PubMedCrossRef

West, L., Brunssen, S. H., & Waldrop, J. (2009). Review of the evidence for treatment of children with autism with selective serotonin reuptake inhibitors. Journal for Specialists in Pediatric Nursing,14(3), 183–191. PubMedCrossRef

White, S. W., Albano, A. M., Johnson, C. R., Kasari, C., Ollendick, T., Klin, A., et al. (2010). Development of a cognitive-behavioral intervention program to treat anxiety and social deficits in teens with high-functioning autism. Clinical Child and Family Psychology Review,13(1), 77–90. PubMedCrossRef

Wood, J. J., Drahota, A., Sze, K., Har, K., Chiu, A., & Langer, D. A. (2009a). Cognitive behavioral therapy for anxiety in children with autism spectrum disorders: A randomized, controlled trial. Journal of Child Psychology and Psychiatry,50(3), 224–234. PubMedCrossRef

Wood, J. J., Drahota, A., Sze, K., Van Dyke, M., Decker, K., Fujii, C., et al. (2009b). Brief report: Effects of cognitive behavioral therapy on parent-reported autism symptoms in school-age children with high-functioning autism. Journal of Autism and Developmental Disorders,39(11), 1608–1612. PubMedCrossRef

Wood, J. J., Fujii, C., & Renno, P. (2011). Cognitive behavioral therapy in high-functioning autism: Review and recommendations for treatment development. In B. Reichow, P. Doehring, D. V. Cicchetti, & F. R. Volkmar (Eds.), Evidence-based practices and treatments for children with autism (pp. 197–230). New York, NY: Springer. CrossRef

Zandt, F., Prior, M., & Kyrios, M. (2007). Repetitive behaviour in children with high functioning autism and obsessive compulsive disorder. Journal of Autism and Developmental Disorders,37(2), 251–259. PubMedCrossRef

Titel: Translation of Anxiety Treatment to Youth with Autism Spectrum Disorders
Auteurs:: Robert R. Selles
Eric A. Storch
Publicatiedatum: 01-04-2013
DOI: https://doi.org/10.1007/s10826-012-9593-1
Uitgeverij: Springer US
Tijdschrift: Journal of Child and Family Studies
Uitgave 3/2013
Print ISSN: 1062-1024
Elektronisch ISSN: 1573-2843

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Tip

Swipe om te navigeren naar een ander artikel

Abstract

Log in om toegang te krijgen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Psychologie Totaal

Andere artikelen Uitgave 3/2013

Psychiatric Comorbidity in Children with Autism Spectrum Disorders: A Comparison with Children with ADHD

Parent Perspectives of an Evidence-Based Intervention for Children with Autism Served in Community Mental Health Clinics

Turkish Mothers’ Coping with Children’s Negative Emotions: A Brief Report

Self-Reported Depressive Symptoms Have Minimal Effect on Executive Functioning Performance in Children and Adolescents

Maternal Knowledge and Behaviors Regarding Discipline: The Effectiveness of a Hands-on Education Program in Positive Guidance

Parental Depression and Economic Disadvantage: The Role of Parenting in Associations with Internalizing and Externalizing Symptoms in Children and Adolescents